CVT-ISR First in Human Trial for Coronary In-Stent Restenosis
NCT05731700 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 51
Last updated 2026-05-15
Summary
The goal of this first in human study is to assess the safety and inhibition of restenosis of the CVT Everolimus-coated PTCA Catheter in the treatment of subjects presenting in-stent restenotic lesions in native coronary arteries.
Conditions
- In-stent Restenosis
Interventions
- DEVICE
-
Drug Eluting Balloon
PCI of in-stent restenosis
Sponsors & Collaborators
-
Abbott Medical Devices
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-10-20
- Primary Completion
- 2022-09-19
- Completion
- 2025-05-08
Countries
- France
- Georgia
- Lithuania
- Spain
Study Locations
More Related Trials
-
Wall Shear Stress and Neointimal Healing Following PCI in Angulated Coronary Vessels
NCT02098876 ·Status: COMPLETED ·Phase: NA
-
COronary Native Artery First in Man Investigation of ISA 247 Elution to Prevent Restenotic Mechanisms (CONFIRM 1)
NCT00689767 ·Status: TERMINATED ·Phase: NA
-
Non-acute Coronary occlusIon Treated By Everolimus ELuting Stent
NCT00793221 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Efficacy of Paclitaxel-releasing Balloon Catheter System Versus the Everolimus-Eluting Stent System for Treatment of In-Stent Restenosis Lesions - Harmonizing Optimal Strategy for Treatment of In-Stent Restenosis Lesions (The HOST-ISR Trial) -
NCT01093300 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Evaluation of Patients With Everolimus-eluting Stent Xience V® Implanted in the Treatment of Restenosis in Non-coated Metallic Stent (BMS In-stent Restenosis) During a 2 Year Clinical Follow-up Period
NCT00882219 ·Status: COMPLETED ·Phase: PHASE3
-
RIBS V (Restenosis Intra-stent of Bare Metal Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent)
NCT01239953 ·Status: UNKNOWN ·Phase: PHASE4
-
Comparison of the Vasomotor Function and Myocardial Flow in Patients Treated With Bioresorbable and Metallic Stents at 1 Year
NCT02738658 ·Status: COMPLETED ·Phase: PHASE4
-
Drug-eluting Stents to Treat Unprotected Coronary Left Main Disease
NCT00598637 ·Status: COMPLETED ·Phase: PHASE4
-
First-in-Man Study: Safety and Efficacy of INC-1 Bare Metal Stent in the Novo Coronary Lesions.
NCT03375411 ·Status: WITHDRAWN ·Phase: NA
-
Clinical Investigation for Everolimus Drug Eluting Stent
NCT06769217 ·Status: COMPLETED ·Phase: PHASE4
-
Safety and Efficacy of DCB Therapy for ISR Under the Guidance of QFR (UNIQUE-DCB-II Study )
NCT04119986 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
New Generation Drug Eluting Stent for In-stent Restenosis of Drug Eluting Stent( RESTENT-ISR Trial )
NCT01365572 ·Status: UNKNOWN ·Phase: PHASE4
-
A Clinical Trial to Assess the Agent Paclitaxel Coated PTCA Balloon Catheter for the Treatment of Subjects With In-Stent Restenosis (ISR) - Long Lesion Cohort
NCT06492174 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Registry To Evaluate Safety And Effectiveness Of Everolimus Drug Eluting Stent For Coronary Revascularization
NCT01157455 ·Status: UNKNOWN ·Phase: PHASE4
-
Intracoronary Stenting and Restenosis - Randomized Trial of Drug-eluting Stent Implantation or Drug-coated Balloon Angioplasty According to Neointima Morphology in Drug-eluting Stent Restenosis 5
NCT05544864 ·Status: RECRUITING ·Phase: NA
-
Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent and Platelet AggregatioN studIeS for TreatMent of Acute Myocardial InfarctionTreatment of ST-elevation Acute Myocardial Infarction
NCT02014753 ·Status: COMPLETED
-
Treatment of Coronary In-stent Restenosis (ISR) by a Sirolimus Coated or a Paclitaxel Coated Balloon
NCT03242096 ·Status: COMPLETED ·Phase: NA
-
RIBS IV (Restenosis Intra-stent of Drug-eluting Stents: Paclitaxel-eluting Balloon vs Everolimus-eluting Stent)
NCT01239940 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Rotablator on Balloon Resistant Calcified Coronary Lesion
NCT01887704 ·Status: COMPLETED ·Phase: NA
-
A Clinical Evaluation of Everolimus Eluting Coronary Stents in the Treatment of Patients With ST-segment Elevation Myocardial Infarction: EXAMINATION Study
NCT00828087 ·Status: COMPLETED ·Phase: NA
-
SPIRIT FIRST Clinical Trial of the Abbott Vascular XIENCE V® Everolimus Eluting Coronary Stent System
NCT00180453 ·Status: COMPLETED ·Phase: PHASE3
-
Sirolimus-Eluting Stent vs. Intravascular Brachytherapy in In-Stent Restenotic Coronary Artery Lesions(SISR)
NCT00231257 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized, Two-arm, Non-inferiority Study Comparing Endeavor-Resolute Stent With Abbot Xience-V Stent
NCT00617084 ·Status: COMPLETED ·Phase: PHASE4
-
XIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE Xpedition SV Japan PMS)
NCT02513732 ·Status: COMPLETED
-
First In Human Study to Assess Safety and Efficacy of the ChampioNIR™ Drug Eluting Peripheral Stent in the Treatment of Patients With Superficial Femoral Artery Disease and/or Proximal Popliteal Artery Disease
NCT06410313 ·Status: RECRUITING ·Phase: NA